Published in Br J Haematol on September 10, 2008
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood (2011) 1.80
Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis (2011) 1.78
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol (2011) 1.74
Comparison of the Luminex xTAG RVP Fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital. J Clin Microbiol (2012) 1.60
Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant (2013) 1.58
Adoptive transfer of virus-specific and tumor-specific T cell immunity. Curr Opin Immunol (2009) 1.36
How I treat influenza in patients with hematologic malignancies. Blood (2009) 1.32
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis (2012) 1.20
Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods. J Clin Microbiol (2012) 1.03
Long-term shedding of influenza A virus in stool of immunocompromised child. Emerg Infect Dis (2010) 1.00
Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res (2012) 0.93
Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biol Blood Marrow Transplant (2010) 0.93
Evaluation of the BioFire FilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens. J Clin Microbiol (2013) 0.90
Respiratory Infections in the U.S. Military: Recent Experience and Control. Clin Microbiol Rev (2015) 0.90
Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biol Blood Marrow Transplant (2014) 0.88
Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One (2014) 0.87
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis (2014) 0.86
Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model. Antiviral Res (2013) 0.85
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis (2011) 0.84
Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. Br J Haematol (2009) 0.83
Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol (2009) 0.82
Current management of parainfluenza pneumonitis in immunocompromised patients: a review. Infect Drug Resist (2012) 0.81
New Epidemiological and Clinical Signatures of 18 Pathogens from Respiratory Tract Infections Based on a 5-Year Study. PLoS One (2015) 0.80
Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients. Adv Virol (2011) 0.76
Predictive value of testing nasopharyngeal samples for respiratory viruses in the setting of lower respiratory tract disease. J Clin Microbiol (2014) 0.75
Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation. Clin Chest Med (2016) 0.75
T-cell therapy for viral infections following transplantation: why stop at three viruses? Mol Ther (2012) 0.75
How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. Blood (2016) 0.75
Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea. Yonsei Med J (2017) 0.75
DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation. Case Rep Med (2016) 0.75
Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis. Oncotarget (2017) 0.75
A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32
Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A (2005) 14.71
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med (1997) 6.23
Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis (2002) 6.09
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet (2000) 5.03
Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J Clin Microbiol (2007) 4.55
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med (2006) 4.42
An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med (2005) 4.24
High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol (2007) 4.15
Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis (2004) 3.01
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol (2001) 2.94
Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med (2006) 2.85
Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin Infect Dis (2006) 2.38
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis (1999) 2.28
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis (1996) 2.12
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood (2003) 2.06
Human bocavirus in French children. Emerg Infect Dis (2006) 2.04
Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol (1996) 1.98
MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol (2007) 1.98
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) (2006) 1.96
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol (2006) 1.94
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood (2001) 1.92
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood (2007) 1.85
Bocavirus infection in hospitalized children, South Korea. Emerg Infect Dis (2006) 1.76
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2001) 1.74
The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant (2005) 1.71
An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis (1992) 1.69
Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. J Clin Microbiol (2007) 1.67
Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clin Infect Dis (2007) 1.66
Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev (2006) 1.65
Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis (1994) 1.57
Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone Marrow Transplant (1999) 1.56
Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis (1999) 1.55
Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant (1993) 1.52
Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology (1994) 1.51
Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis (2003) 1.48
Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant (1999) 1.46
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis (2006) 1.46
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant (2005) 1.45
Evaluation of the Prodesse Hexaplex multiplex PCR assay for direct detection of seven respiratory viruses in clinical specimens. Am J Clin Pathol (2001) 1.44
Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med (1997) 1.44
Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant (2001) 1.44
Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant (2000) 1.42
Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med (2007) 1.42
High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis (2002) 1.41
Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases. Bone Marrow Transplant (2007) 1.37
Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis (2001) 1.29
Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res (2003) 1.29
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis (2006) 1.29
Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol (1998) 1.27
Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis (2001) 1.26
Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics (2002) 1.25
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2003) 1.24
Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant (2004) 1.24
Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol (2006) 1.23
Influenza A in immunocompromised patients. Clin Infect Dis (1993) 1.22
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis (1995) 1.17
Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis (2001) 1.16
Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant (2001) 1.14
Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother (2005) 1.13
Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant (2003) 1.12
Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J (1988) 1.11
Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant (1989) 1.11
Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant (2000) 1.10
Rhinovirus chemotherapy. Antiviral Res (2006) 1.10
Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis (2007) 1.06
Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation (2006) 1.06
An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant (2003) 1.06
Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev (2008) 1.05
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant (1997) 1.05
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant (2007) 1.04
Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis (2002) 1.04
Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis (1993) 1.04
Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant (2001) 1.01
Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. New Microbiol (2007) 1.01
A meta-analysis of zinc salts lozenges and the common cold. Arch Intern Med (1997) 1.01
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J (2007) 0.99
Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother (1996) 0.98
Adenovirus nephritis in hematopoietic stem-cell transplantation. Transplantation (2004) 0.98
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis (2007) 0.96
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. Br J Haematol (2002) 0.94
Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant (1999) 0.92
Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant (2000) 0.92
Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med (1997) 0.90
Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 0.90
Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy. Clin Infect Dis (2000) 0.88
Array-based nano-amplification technique was applied in detection of hepatitis E virus. J Biochem Mol Biol (2006) 0.87
The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation. Bone Marrow Transplant (2002) 0.86
Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol (2007) 0.85
Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin Infect Dis (2004) 0.84
Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant. Bone Marrow Transplant (2001) 0.82
Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. Bone Marrow Transplant (2000) 0.81
Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. J Pediatr Hematol Oncol (2007) 0.81
Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation. J Infect Dis (2002) 0.80
Fitting new technologies into the safety paradigm: use of microarrays in transfusion. Dev Biol (Basel) (2007) 0.78
Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant (1999) 0.77